Incidence of Amantadine‐Resistant Influenza A Viruses in Sentinel Surveillance Sites and Nursing Homes in Niigata, Japan
Open Access
- 1 October 2000
- journal article
- research article
- Published by Wiley in Microbiology and Immunology
- Vol. 44 (10) , 833-839
- https://doi.org/10.1111/j.1348-0421.2000.tb02571.x
Abstract
We surveyed the incidence of amantadine‐resistant influenza A viruses both at sentinel surveillance sites and at nursing homes, and verified their types of change by partial nucleotide sequence analysis of the M2 protein. Fifty‐five influenza A viruses from 27 sentinel surveillance sites during six influenza seasons from 1993 to 1999, and 26 influenza A viruses from 5 nursing homes from 1996 to 1999 were examined for susceptibility to the drug by virus titration in the presence or absence of amantadine. While amantadine‐resistant viruses were not found in sentinel surveillance sites, a high frequency of resistance (8/26, 30.8%) in nursing homes was observed. Resistant viruses can occur quickly and be transmitted when used in an outbreak situation at nursing homes, where amantadine is used either for neurologic indications or for influenza treatment. Eight resistant viruses had a single amino acid change of the M2 protein at residue 30 or 31. In vitro, all 11 sensitive viruses turned resistant after 3 or 5 passages in the presence of 2 μg/ml amantadine, and they showed an amino acid change at residue 27, 30, or 31. The predominant amino acid substitution in the M2 protein of resistant viruses is Ser‐31‐Asp (a change at 31, serine to asparagine). The results indicate that a monitoring system for amantadine‐resistant influenza viruses should be established without delay in Japan.Keywords
This publication has 23 references indexed in Scilit:
- Low Incidence of Rimantadine Resistance in Field Isolates of Influenza A VirusesThe Journal of Infectious Diseases, 1999
- Amantadine susceptibility in influenza A virus isolates: determination methods and lack of resistance in a Canadian sample, 1991–1994Clinical and Diagnostic Virology, 1997
- Prolonged Shedding of Amantadine-Resistant Influenza A Viruses by Immunodeficient Patients: Detection by Polymerase Chain Reaction-Restriction AnalysisThe Journal of Infectious Diseases, 1995
- Production of the M2 protein of influenza A virus in insect cells is enhanced in the presence of amantadineJournal of General Virology, 1993
- Influenza virus M2 protein has ion channel activityPublished by Elsevier ,1992
- Recovery of drug-resistant influenza A virus during therapeutic use of rimantadineAntimicrobial Agents and Chemotherapy, 1991
- Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in FamiliesNew England Journal of Medicine, 1989
- Resistance of Influenza A Virus to Amantadine and Rimantadine: Results of One Decade of SurveillanceThe Journal of Infectious Diseases, 1989
- Efficacy of Influenza Vaccine in Nursing HomesJAMA, 1985